期刊文献+

磷酸雌二醇氮芥治疗晚期前列腺癌的临床观察 被引量:2

暂未订购
导出
摘要 目的 通过观察磷酸雌二醇氮芥治疗晚期前列腺癌的效果及其副作用。方法 从1991年2月~1998年4月对36例晚期前列腺癌行去势术并每日口服磷酸雌二醇氮芥治疗,观察其疗效。结果 36例前列腺癌中,有25例为CR,5例为PR,有效率达83%。盆腔淋巴结转移8例,7例转移肿大淋巴结消失,有效率(7/8)88%。骨转移16例,其中12例骨转移灶消失,有效率(12/16)75%。结论 磷酸雌二醇氮芥治疗中低分化的晚期前列腺癌效果非常显著,明显改善病人生活质量。
作者 付成 庞兆刚
机构地区 辽宁省肿瘤医院
出处 《实用肿瘤学杂志》 CAS 2000年第4期301-301,共1页 Practical Oncology Journal
  • 相关文献

参考文献4

  • 1[1]Fukuoka H,Ishibashi Y,Sakai N,et al. The evaluation of the effect of Estracyt on prostatic cancer. Hinyokika kiyo 1991;Jan;37(1):91~97
  • 2[2]Morote J,Lopez-Pacios MA,Ahmad A,et al. Treatment of hormone-refractory prostate cancer with estramustine phosphate.Actas Urol Esp 1991 Sel-Oct;15(5):421
  • 3[3]Van Poppel H,Baert L. The present role of estramustine phosphate in advanced prostate cancer. Prog Clin Biol Res 1991;370:323~341
  • 4[4]Hudes G. Estramustine-based chemotherapy. Semi Urol Oncol 1997 Feb;15(1) :13~19

同被引文献15

  • 1Hartmann RW, Ehmer PB, Haidar S, et al. Inhibition of CYP 17, a new strategy for the treatment of prostate cancer. Arch Pharm ( Weinheim), 2002,335 (4): 119.
  • 2Madigan MP, Gao YT, Deng J,et al. CYP17 polymorphisms in relation to risks of prostate cancer and benign prostatic hyperplasia: a population - based study in China. Int J Cancer, 2003 ,107(2) :271.
  • 3Yamada Y, Watanabe M, Murata M, et , al. Impact of genetic polymorphisms of 17 - hydroxylase cytochrome P -450 (CYP17)and steroid 5alpha - reductase type Ⅱ (SRD5A2) genes on prostate - cancer risk among the Japanese population. Int J Cancer,2001 ,92(5) :683.
  • 4Ho SM. Estrogens and anti -estrogens: key mediators of prostate carcinogenesis and newtherapeutic candidates. J Cell Biochem,2004 ,91(3) :491.
  • 5Chen TC, Holick MF. Vitamin D and prostate cancer prevention and treatment. Trends Endocrinol Metab,2003 , 14 (9) :423.
  • 6Stewart LV, Weigel NL. Vitamin D and prostate cancer. Exp Biol Med (Maywood) ,2004 ,229(4) :277.
  • 7Liu XM, Jiang JD, Ferrari AC, et al. Unique induction of p21(WAF1/CIP1) expression by vinorelbine in androgen - independent prostate cancer cells. Br J Cancer,2003 ,89(8) :1566.
  • 8Athanasiadis A, Tsavdaridis D, Rigatos SK,et al. Hormone refractory advanced prostate cancer treated with estramustine and paclitaxel combination. Anticancer Res, 2003 ,23 (3C) :3085.
  • 9王平.药物治疗雄激素非依赖型前列腺癌的研究进展[J].国外医学(泌尿系统分册),1997,17(5):201-203. 被引量:1
  • 10李炎唐.黄体生成素释放激素-A治疗前列腺癌睾丸切除后复发转移疗效的探讨(附5例报告)[J].临床泌尿外科杂志,1998,13(12):519-521. 被引量:7

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部